Ads
related to: breakthroughs in multiple myeloma- Patient Assistance
Co-pay assistance, referrals &
more services to help your patients
- Set Patient Expectations
Learn how to educate patients and
manage their expectations.
- Expert Insights
Get insights from experts in the
field of multiple myeloma.
- Request a Rep
Complete a request form and have
a rep reach out to you.
- Patient Assistance
freshdiscover.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. [6] Often, no symptoms are noticed initially. [10] As it progresses, bone pain, anemia, renal insufficiency, and infections may occur. [10]
Down regulation of IRF4 promotes the death of both myeloma and lymphoma cells. About Multiple Myeloma Multiple myeloma (MM) is a rare blood cancer affecting plasma cells. Approximately 36,000 people in the United States are diagnosed with MM each year. Despite advances in treatment, multiple myeloma remains incurable.
“The latest MRD data showcases the advances of CARVYKTI and further demonstrates why it is a leading treatment for patients with multiple myeloma,” said Ying Huang, Ph. D., Chief Executive Officer of Legend Biotech.
In the United States, Janssen received breakthrough therapy designation for talquetamab in June 2022, for the treatment of adults with relapsed or refractory multiple myeloma, who have previously received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody. [13]
To treat relapsed or refractory multiple myeloma after at least four lines of therapy [1] Fabhalta: To treat paroxysmal nocturnal hemoglobinuria [1] Izervay: To treat geographic atrophy secondary to age-related macular degeneration [1] Leqembi: To treat Alzheimer's disease [1] Loqtorzi
Sarclisa has previously been approved for use as a fallback therapy for certain cases of multiple myeloma after standard treatments have failed. The French drugmaker, a market leader in anti ...
Ads
related to: breakthroughs in multiple myelomafreshdiscover.com has been visited by 100K+ users in the past month